格隆汇3月31日丨福森药业(01652.HK)公告,截至2024年12月31日止年度的收益约为人民币3.26亿元,同比减少约42.4%。公司股权持有人应占亏损约为人民币1.89亿元,而截至2023年12月31日止年度的亏损约为人民币3630万元。年度的每股基本亏损约为人民币26分,而截至2023年12月31日止年度每股基本亏损约为人民币5分。董事会不建议派付截至2024年12月31日止年度的任何...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.